Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and measured how using Shared Medical Appointments, continuous glucose monitors ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...